Alar Pharmaceuticals 

TWD91.90
0
+TWD1.20+1.32% 05:30 Today

Statistics

Day High
92.3
Day Low
90.7
52W High
317
52W Low
90.6
Volume
27,739
Avg. Volume
78,280
Mkt Cap
6.14B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jul 25
TWD0.25
Jun 24
TWD1.50
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
-83.33%

Earnings

5NovExpected
Q1 2025
Q1 2026
Q2 2026
Next
0.05
0.39
0.72
1.05
Expected EPS
N/A
Actual EPS
N/A

Financials

-2,894.41%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
2.75MRevenue
-79.68MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.
Show more...
CEO
Yung Shun Wen
Employees
32
Country
Taiwan
ISIN
TW0006785009

Listings

0 Comments

Share your thoughts

FAQ

What is Alar Pharmaceuticals stock price today?
The current price of 6785.TWO is TWD91.90 TWD — it has increased by +1.32% in the past 24 hours. Watch Alar Pharmaceuticals stock price performance more closely on the chart.
What is Alar Pharmaceuticals stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Alar Pharmaceuticals stocks are traded under the ticker 6785.TWO.
Is Alar Pharmaceuticals stock price growing?
6785.TWO stock has fallen by -3.57% compared to the previous week, the month change is a -5.94% fall, over the last year Alar Pharmaceuticals has showed a -58.13% decrease.
What is Alar Pharmaceuticals market cap?
Today Alar Pharmaceuticals has the market capitalization of 6.14B
When is the next Alar Pharmaceuticals earnings date?
Alar Pharmaceuticals is going to release the next earnings report on November 05, 2026.
What is Alar Pharmaceuticals revenue for the last year?
Alar Pharmaceuticals revenue for the last year amounts to 2.75M TWD.
What is Alar Pharmaceuticals net income for the last year?
6785.TWO net income for the last year is -79.68M TWD.
Does Alar Pharmaceuticals pay dividends?
Yes, 6785.TWO dividends are paid annual. The last dividend per share was 0.25 TWD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Alar Pharmaceuticals have?
As of September 04, 2026, the company has 32 employees.
In which sector is Alar Pharmaceuticals located?
Alar Pharmaceuticals operates in the Health & Wellness sector.
When did Alar Pharmaceuticals complete a stock split?
Alar Pharmaceuticals has not had any recent stock splits.
Where is Alar Pharmaceuticals headquartered?
Alar Pharmaceuticals is headquartered in Taichung, Taiwan.